메니에르병 = Meniere's Disease

다국어 초록 (Multilingual Abstract)

Hydrops of the endolymphatic space in the inner ear deteriorates hearing and balance

function. This idiopathic syndrome of endolymphatic hydrops is Meniere's disease and is

characterized by episodic vertigo, fluctuating hearing loss, tinnitus and ear fullness. For the

pathophysiologic mechanisms of the episode, the progression of the hydrops leads to ruptures in

the membranes separating endolymph from perilymph, producing a sudden increase in potassium

concentration in the perilymph. Recurrent episodes may interfere with routine daily

activities and sometimes accompany sudden drop attacks, so called Tumarkin's otolithic crisis,

which may lead to serious injuries. Life style modification, low salt diet and prescription of

diuretics have been traditionally tried in order to relieve endolymphatic hydrops. Surgical and

destructive treatment options are necessary in selected intractable patients depending on the

frequency of vertigo, severity of hearing loss and the possibility of bilateral involvement. However,

a large proportion of these patients shows a spontaneous cure of vertigo with the aggravation of

hearing loss (burnt out stage) over time. The goal of treatment is trying not to make the patient

worse than this natural course of disease.

참고문헌 (Reference)

1 Gacek RR, 22 : 241-250, 2001

2 "on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc" 113 : 181-185, 1995

3 Naganuma H, "Water may cure patients with Meniere disease" 116 : 1455-1460, 2006

4 Claes J, "Van de Heyning PH. Medical treatment of Meniere’s disease: a review of literature" 526 : 37-42, 1997

5 Yoo TJ, "Type II collagen autoimmunity in otosclerosis and Meniere’s disease" 217 : 1153-1155, 1982

6 Hebbar GK, "Threedimensional analysis of 61 human endolymphatic ducts and sacs in ears with and without Menière’s disease" 100 : 219-225, 1991

7 Tumarkin A, "Thoughts on the treatment of labyrinthopathy" 80 : 1041-1053, 1966

8 Paparella MM, "The natural course of Meniere’s disease" 29-40, 1994

9 Brown DH, "The membrane rupture theory of Meniere’s disease-is it valid?" 98 : 599-601, 1988

10 Schmidt JT, "The clinical drug trial in Meniere’s disease with emphasis on the effect of betahistine SR" 497 : 1-189, 1992

11 Paparella MM, "The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere’s disease and its symptoms (mechanical and chemical)" 99 : 445-451, 1985

12 Stahle J, "The caloric reaction in Meniere’s disease" 77 : 1629-1643, 1967

13 McKee GJ, "Surgical control of vertigo in Meniere’s disease" 16 : 216-227, 1991

14 Eggermont JJ, "Summating potentials in electrocochleography: Relation to hearing disorders. In: Electrocochleography" University Press 67-88, 1967

15 McClure JA, "Recovery nystagmus in Meniere’s disease" 91 : 1727-1737, 1981

16 Arnold W, "Qualitative detection of immunoglobulins in the human endolymphatic sac" 63 : 464-467, 1984

17 Kotimaki J, "Prevalence of Meniere disease in Finland" 109 : 748-753, 1999

18 Nadol JB Jr, "Positive Hennebert’s sign in Meniere’s disease" 103 : 524-530, 1977

19 Thomsen J, "Placebo effect in surgery for Meniere’s disease. A double-blind, placebocontrolled study on endolymphatic sac shunt surgery" 107 : 271-277, 1981

20 Calenoff E, "Patients with Menière’s disease possess IgE reacting with herpes family viruses" 121 : 861-864, 1995

21 Schuknecht HF, "Pathophysiology of Meniere’s diease. In: Controversial Aspects of Meniere’s Disease" Thieme 46-54, 1986

22 Schuknecht HF, "Pathology of the Ear" Lea & Febiger 245-275, 1993

23 Paparella MM, "Pathogenesis of Menieres disease and Meniere’s syndrome" 406 : 10-25, 1984

24 Tumarkin A, "Otolithic catastrophe, a new syndrome" 2 : 175-177, 1936

25 Dohlmann GF, "On the mechanism of the Menière attack" 212 : 301-307, 1976

26 Torok N, "Old and new in Meniere disease" 87 : 1870-1877, 1977

27 Valvassori GE, "Multidirectional and computerized tomography of the vestibular aqueduct in Meniere’s disease" 93 : 547-550, 1984

28 Tasaki I, "Modification of the cochlear microphonics and action potentials by KCI solution and by direct current" 12 : 497-512, 1952

29 Eggermont JJ, "Methods in electrocochleography" 316 : 17-24, 1974

30 Costa SS, "Meniere’s disease: overview, epidemiology and natural history" 35 : 455-495, 2002

31 Wladislavosky -Waserman P, "Meniere’s disease: A 36-year epidemiologic and clinical study in Rochester" 94 : 1098-1102, 1984

32 Lee WS, "Meniere’s disease. In: Equilibrium and Disequilibrium" Koonja Publication 475-502, 2005

33 Meyerhoff WL, "Meniere’s disease in children" 88 : 1504-1511, 1978

34 Vasama JP, "Meniere’s disease and endolymphatic hydrops without Meniere’s symptoms: temporal bone histopathology" 199 : 297-301, 1999

35 Cawthorne T, "Meniere’s disease" 47 : 663-670, 1954

36 Meniere P, "Memoire sur des lesions de l’oreille interne donnant lieu a des symtomes de congestion cerebrale apoplectiforme" 38 : 597-601, 1861

37 Thomas K, "Long - term follow-up of 610 cases of Meniere’s disease" 64 : 853-856, 1971

38 Okuno T, "Localization, frequency, and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Menière’s disease" 96 : 438-445, 1987

39 Furuta Y, "Latent herpes simplex virus type 1 in human vestibular ganglia" 503 : 85-89, 1993

40 Chia SH, "Intratympanic gentamicin therapy for Ménière’s disease: a meta-analysis" 25 : 544-552, 2004

41 Okafor BC, "Incidence of Meniere’s disease" 98 : 775-779, 1984

42 Stahle J, "Incidence of Meniere’s disease" 104 : 99-102, 1978

43 Harris JP, "Immunology of the inner ear: evidence of local antibody production" 93 : 157-162, 1984

44 Koo JW, "Immunologic screening test and type II collagen autoimmunity in Meniere’s disease" 4 : 13-16, 2005

45 Rask-Andersen H, "Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac" 89 : 283-294, 1980

46 Densert B, "Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière’s disease: a clinical placebo-controlled study" 18 : 726-733, 1997

47 Arnold W, "Herpes simplex virus antibodies in the perilymph of patients with Meniere disease" 123 : 53-56, 1997

48 Pender DJ, "Gentamicin tympanoclysis: effects on the vestibular secretory cells" 6 : 358-367, 1985

49 Shea JJ Jr, "External aperture of the vestibular aqueduct in Meniere’s disease" 21 : 351-355, 2000

50 Dohlmann GF, "Experiments on the mechanism of Meniere’s attacks" 19 : 73-, 1965

51 Watanabe Y, "Epidemiological and clinical characteristics of Meniere’s disease in Japan" 519 : 206-210, 1995

52 Arts HA, "Dianostic test for endolymphatic hydrops" 30 : 987-1005, 1997

53 Owen Black F, "Diagnosis and management of drop attacks of vestibular origin: Tumarkin’s otolithic crisis" 90 : 256-262, 1982

54 Arenberg IK, "Danish sham surgery recisited: Intraoperative electrocobhleographic evidence that mastoidectomy/drilling actibely changes hydrops" 533-536, 1994

55 Balkany T, "Bilateral aspects of Meniere’s disease: an underestimated clinical entity" 13 : 603-609, 1980

56 McCabe BF, "Autoimmune sensorineural hearing loss" 88 : 585-589, 1979

57 Koo JW, "Association of HLA-DR and type II collagen autoimmunity with Meniere’s disease" 61 : 99-103, 2003

58 Kiang NYS, "An auditory physiologist’s view of Meniere’s syndrome. In 2nd Int Symp Men Dis" Kugler 13-24, 1989

59 Schuknecht HF, "Ablation therapy in the management of Meniere’s disease" 132 : 1-42, 1957